Guardant Health
GH
#2543
Rank
A$8.89 B
Marketcap
$71.99
Share price
23.10%
Change (1 day)
104.49%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: A$8.89 Billion

As of January 2025 Guardant Health has a market cap of A$8.89 Billion. This makes Guardant Health the world's 2543th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$8.89 B47.11%
2024A$6.04 B25.47%
2023A$4.81 B17.7%
2022A$4.09 B-70.81%
2021A$14.02 B-16.3%
2020A$16.75 B59.88%
2019A$10.48 B129.04%
2018A$4.57 B

End of Day market cap according to different sources

On Jan 21st, 2025 the market cap of Guardant Health was reported to be:

A$8.89 Billion
by Nasdaq info icon info icon
A$8.89 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$35.26 B 296.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.06 B-54.32%๐Ÿ‡บ๐Ÿ‡ธ USA